Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME.

Area of Science:

• Immunology
• Oncology
• Cellular Biology

Background:

• Myeloid immune cells (MICs) are crucial first responders to pathogens and cellular homeostasis disruptions.
• Cancer involves altered homeostasis, with MICs recognizing these changes through pattern recognition receptors (PRRs).
• Cytosolic PRRs, like cGAS/STING, detect double-stranded DNA (dsDNA), with longer dsDNA triggering stronger signaling.

Purpose of the Study:

• To discuss tumor-supportive alterations in MICs within the tumor microenvironment (TME).
• To emphasize the role of cGAS/STING signaling in modifying the tumor immune microenvironment (TIME).
• To explore the potential of modulating MIC-specific cGAS/STING signaling for cancer immunotherapy.

Main Methods:

• Review of existing literature on MICs, PRRs, and cGAS/STING signaling in cancer.
• Analysis of how cGAS/STING activation influences the TME.
• Discussion of therapeutic strategies targeting cGAS/STING in MICs.

Main Results:

• cGAS/STING signaling in MICs can promote tumor growth by altering the TME.
• The strength of cGAS/STING activation correlates with type 1 interferon and cytokine production.
• Dysregulation of cGAS/STING in MICs contributes to tumor progression.

Conclusions:

• Modulating MIC-specific cGAS/STING signaling is a promising avenue for cancer immunotherapy.
• Targeting cGAS/STING can reprogram the TIME to enhance anti-tumor immunity.
• Understanding cGAS/STING pathways in MICs is critical for developing novel cancer treatments.